Why did OpenAI win the $200 million defense contract?
How will SoftBank’s T-Mobile share sale affect the market?
What impact did the Senate GOP’s Trump tax bill have?
Why is Trump launching a Bitcoin and Ether ETF?
How did Israel-Iran conflict influence oil prices today?
Why is WhatsApp introducing ads and subscriptions now?
What caused the recent surge in AMD’s stock price?
Biotech pauses trial after second patient death linked to gene therapy
washingtonpost.com/business/2025/06/16/sarepta-elevidys-duchenne-patient-deathSarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular dystrophy.
This story appeared on washingtonpost.com, 2025-06-16 21:20:51.